Nancy Torres Luna, MD
Nancy Torres Luna, MD
Specialty: Blood and Marrow Transplant and Cellular Immunotherapy
Program: Blood and Marrow Transplant and Cellular Immunotherapy
Language(s): English, Spanish
-
Overview
Cancer Focus:
Leukemia, Myelodysplastic Syndromes (MDS)Dr. Torres Luna received her MD degree from the Universidad Peruana Cayetano Heredia, Lima, Peru. She completed an Internal Medicine Residency at the University of Central Florida, Orlando, followed by a Hematology and Medical Oncology Fellowship at the University of Rochester, New York. She most recently completed a Blood and Marrow Transplant and Cellular Therapy Fellowship at Stanford University, California. -
Publications
- Pidala JA, Cieri N, Schell MJ, Song X, Shao Y, Cao B, Du D, Thapa R, Betts BC, Janssen W, Cubitt C, Yoder SJ, O'Leary MF, Beato F, Veerapathran A, Menges MA, Burton M, Bejanyan N, Castaneda-Puglianini OA, Elmariah H, Faramand RG, Fernandez HF, Hansen DK, Jain MD, Khimani F, Lazaryan A, Liu HD, Locke FL, Mirza AS, Mishra A, Nieder M, Nishihori T, Ochoa L, Perez LE, Perna F, Ramlal R, Torres NE, Anasetti C. Expanded antigen-specific donor regulatory T cells for GVHD prevention. Blood. 2026 Jun. Pubmedid: 42322116.
- Pidala JA, Kim J, Laborde J, Knott S, Mogili K, Zinn J, Monroe AR, Faramand R, Ramlal R, Khimani F, Hansen DK, Torres Luna NE, Jain MD, Perez LE, Mishra A, Ghalehsari N, Castaneda-Puglianini OA, Alsina M, Perna F, Nieder M, Mirza AS, Liu HD, Nishihori T, Ali A, Chellapandian D, Locke FL, Bejanyan N, Anasetti C, Lazaryan A. Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis. Blood Adv. 2026 Jul. Pubmedid: 42480215.
- Ananth S, Torres NE, Sahaf B, Mikkilineni L, Fernandez-Pol S, Salmi D, Negrin RS, Shiraz P, Smith M, Bharadwaj S, Weng WK, Kennedy VE, Dahiya S, Muffly LS, Miklos DB, Frank MJ, Hosoya H, Sidana S. Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy. Blood Adv. 2025 Aug.9(15):3832-3836. Pubmedid: 40353815. Pmcid: PMC12329291.
- Moore JW, Torres N, Superdock M, Mendler JH, Loh KP. How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia. CURR TREAT OPTION ON. 2022 Aug.23(8):1086-1103. Pubmedid: 35687257. Pmcid: PMC9898635.
- Durer C, Comba IY, Durer S, Torres Luna N, Jignesh P, Carilli A. Seminoma metastasized to the prostate: A case report and literature review. Urol Case Rep. 2020 Mar.29:101096. Pubmedid: 31890599. Pmcid: PMC6928271.
- Torres Luna N, Mosquera JE, Comba IY, Kinaan M, Otoya J. A Primary Adrenal Epithelioid Angiomyolipoma (PEComa) in a Patient with Tuberous Sclerosis Complex: Report of a Case and Review of the Literature. Case Rep Med. 2020 Mar.2020:5131736. Pubmedid: 32256603. Pmcid: PMC7103033.
- Comba IY, Torres Luna NE, Cooper C, W Crespo M, Carilli A. A Rare Case of Extramedullary Plasmacytoma Presenting as Massive Upper Gastrointestinal Bleeding. Cureus. 2019 Jan.11(1):e3993. Pubmedid: 30972272. Pmcid: PMC6443515.
- Ferreiro-Neira I, Torres NE, Liesenfeld LF, Chan CH, Penson T, Landesman Y, Senapedis W, Shacham S, Hong TS, Cusack JC. XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer. Clin Cancer Res. 2016 Apr.22(7):1663-1673. Pubmedid: 26603256.
-
Patient Comments
25 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments